Ketamine Treatment Center in Raleigh, NC
Intravenous ketamine therapy holds much promise ever since “robust decreases in depressive symptoms” were first described in clinical trials in 2000.1 Subsequent studies have shown that repeated dosing can sustain initial improvement in symptoms.2
We wanted to make these services available to the public only if we were convinced about their effectiveness and safety. Based on the compelling research, we started the numerous steps to open our business. Before our doors opened, the FDA approved the intranasal version of ketamine for use in Treatment-resistant Depression. We saw this as validating our business model and so we incorporated this therapy into our treatment center.
We offer both intravenous and intranasal ketamine therapy for Depression, PTSD, Anxiety, OCD, and Chronic Pain. While these treatments are revolutionary, we recognize that they represent only one part of the multi-modal therapy for psychiatric disorders. We will integrate care with your psychiatrist and/or primary care provider to promote the best possible results.
- Berman R, Cappiello A, et al. Antidepressant Effects of Ketamine in Depressed Patients. Biol Psychiatry. 2000 Feb 15; 47(4): 351-4.
- Singh J, Fedgchin M, et al. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. Am J Psychiatry. 2016 August; 173(8): 816-826.
- Sanacora G, Frye M, et al; APA Council of Research Task Force on Novel Biomarkers and Treatments. A Consensus Statement of Ketamine in the Treatment of Mood Disorders. JAMA Psychiatry. 2017; 74(4): 399-405.
Bodie Island Lighthouse, Nags Head, NC
Wrightsville Beach, NC